Monday, November 08, 2021 7:48:37 PM
Just reviewing my notes on Regen history, honestly, what Dr Santosh Kesari, Dr Harry Lander, and Dr Thomas Ichim were able to do will be remembered for all time. So far ahead of their time! The patents and multiple FDA IND clearances dont lie!! All encompassing!!! Each are massive associations! Look them up! You find names like American Cancer Association, John Hopkins, And even Cornell Dean of Research!!!
Yup. I know what I own!
Activily being reinstated FDA INDs already 6 months into reactivation, leading to a Multiple INDs in active mRNA Human Clinical Trials company. With Funding and Collaborations to choose because of impressive past associations, the undeniable science, and current mRNA craze.
Then there is the undeniable Patent protections in and all around Nr2F6. The Global NR2F6 advancing studies: which will draw Funding and Collaborations to choose from just from a point of necessity as Regen practically owns NR2F6… and can in fact provide leaps and bound advances over some current studies.
IMHO.
Yup. I know what I own!
Activily being reinstated FDA INDs already 6 months into reactivation, leading to a Multiple INDs in active mRNA Human Clinical Trials company. With Funding and Collaborations to choose because of impressive past associations, the undeniable science, and current mRNA craze.
Then there is the undeniable Patent protections in and all around Nr2F6. The Global NR2F6 advancing studies: which will draw Funding and Collaborations to choose from just from a point of necessity as Regen practically owns NR2F6… and can in fact provide leaps and bound advances over some current studies.
IMHO.
Sometimes its Skil, Sometimes its Luc.
I Appreciate All Member Follows!
Desperate Sellers Become Desperate Buyers. Vice Versa
ALL IMHO.
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
